[go: up one dir, main page]

ES2556772T3 - Nicotinamidas sustituidas como moduladores de KCNQ2/3 - Google Patents

Nicotinamidas sustituidas como moduladores de KCNQ2/3 Download PDF

Info

Publication number
ES2556772T3
ES2556772T3 ES10708139.0T ES10708139T ES2556772T3 ES 2556772 T3 ES2556772 T3 ES 2556772T3 ES 10708139 T ES10708139 T ES 10708139T ES 2556772 T3 ES2556772 T3 ES 2556772T3
Authority
ES
Spain
Prior art keywords
carboxylamide
pyridine
fluorophenyl
propylsulfanyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10708139.0T
Other languages
English (en)
Inventor
Sven KÜHNERT
Beatrix Merla
Gregor Bahrenberg
Wolfgang Schröder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40933299&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2556772(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Application granted granted Critical
Publication of ES2556772T3 publication Critical patent/ES2556772T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

Nicotinamidas sustituidas de fórmula general**Fórmula** A1 representa CR10R11o S; A2 representa CR12R13, C(>=O) O, S, S(>=O)2; R1 represnta alquilo (C1-10) o heteroalquilo (C2-10) en cada caso saturado o insaturado, lineal o ramificado, sustituido de forma simple o múltiple o no sustituido; cicloalquilo (C3-10) o tererociclilo, en cada caso saturado o insaturado, sustituido de forma simple o múltiple o no sustituido; arilo o heteroarilo, en cada caso sustituido de forma simple o múltiple o no sustituido; cicloalquilo (C3-10) o heterociclilo unido a través de un alquilo (C1-8) o un heteroalquilo (C2-8), en cada caso saturado o insaturado, sustituido de forma simple o múltiple o no sustituido, pudiendo la cadena alquilo o hereroalquilo en cada caso ser lineal o ramificada, saturada o no saturada, sustituida de forma simple o múltiple o no sistituida; o arilo o heteroarilo unidos a través de un alquilo (C2-8), en cada caso sustituido de forma simple o múltiple o no sustituido, pudiendo la cadena alquilo o heteroalquilo en cada caso ser lienal o ramificada, saturada o insaturada, sustituida de forma simple o múltiple o no sustituida.

Description

imagen1
imagen2
imagen3
imagen4
-
-
---
-
imagen5
-
imagen6
imagen7
imagen8
imagen9
-
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
Tabla 2
Ej. decomp.
Designación química Síntesis análogaal ej. de comp. MD m/z[M+H]+
2
2-(3-ciclohexil-propilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 17 375,1
4
N-(tiofen-2-ilmetil)-2-[2-[3-(trifluorometil)fenoxi]etilsulfanil]piridin-3-carboxilamida 17 439,1
5
2-(4-metil-pentilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 17 335,1
7
2-(4-fenilbutil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 13 351,1
8
2-[3-(bencenosulfonil)propil]-N-(ciclohexilmetil)piridin-3-carboxilamida 13 401,2
9
N-(ciclohexilmetil)-2-(4-fenilbutil)piridin-3-carboxilamida 13 351,2
10
2-[3-(bencenosulfonil)propil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 13 401,1
12
N-(tiofen-2-ilmetil)-2-[3-[[3-(trifluorometil)fenil]sulfonil]propil]piridin-3-carboxilamida 13 469,1
18
N-(tiofen-2-ilmetil)-2-[3-[3-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 17 437,1
19
2-[2-[(4-fluorofenil)sulfanil]propilsulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 16 (de VC002) 419,1
20
N-(tiofen-2-ilmetil)-2-[2-[[3-(trifluorometil)fenil]sulfanil]propilsulfanil]piridin-3-carboxilamida 16 (de VC003) 469,1
22
2-[4-(4-fluorofenil)butil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 21 369,1
23
2-(3-fenilsulfanil-propil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 21 369,1
24
2-[(1-metil-2-fenilsulfanil-etil)sulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 16 (de VC004) 401,1
25
N-(cicloheptilmetil)-2-[4-[3-(trifluorometil)fenil]butil]piridin-3-carboxilamida 17 433,2
26
N-(5-biciclo[2.2.1]heptanilmetil)-2-[4-[3-(trifluorometil)fenil]butil]piridin-3-carboxilamida 17 431,2
27
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[3-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 51 449,2
28
N-(5-biciclo[2.2.1]heptanilmetil)-2-(4-metil-pentilsulfanil)piridin-3-carboxilamida 51 347,2
29
N-(cicloheptilmetil)-2-[3-[(4-fluorofenil)sulfanil]propil]piridin-3-carboxilamida 21 401,2
30
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[(4-fluorofenil)sulfanil]propil]piridin-3-carboxilamida 21 399,2
31
N-(cicloheptilmetil)-2-[3-[[3-(trifluorometil)fenil]sulfonil]propil]piridin-3-carboxilamida 21 483,2
32
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[[3-(trifluorometil)fenil]sulfonil]propil]piridin-3-carboxilamida 21 481,2
33
N-(5-biciclo[2.2.1]heptanilmetil)-2-(3-fenil-propilsulfanil)piridin-3-carboxilamida 51 381,2
34
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[4-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 51 449,2
35
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(4-clorofenil)propilsulfanil]piridin-3-carboxilamida 51 415,2
36
N-[(3,5-difluorofenil)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 417,1
37
N-[(5-clorotiofen-2-il)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 421,1
38
N-[(2,2-dimetil-ciclopropil)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 373,2
39
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(3-fluorofenil)propilsulfanil]piridin-3-carboxilamida 51 399,2
40
N-(ciclohexilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 387,2
41
N-(cicloheptilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 401,2
43
N-(5-biciclo[2.2.1]heptanilmetil)-2-[[3-(4-fluorofenil)-3-oxopropil]sulfanil]piridin-3-carboxilamida 51 413,2
44
N-(5-biciclo[2.2.1]heptanilmetil)-2-[(3-oxo-3-fenilpropil)sulfanil]piridin-3-carboxilamida 51 395,2
45
N-(5-biciclo[2.2.1]heptanilmetil)-2-(hexilsulfanil)piridin-3-carboxilamida 51 347,2
46
N-(5-biciclo[2.2.1]heptanilmetil)-2-(2-fenoxi-etilsulfanil)piridin-3-carboxilamida 51 383,2
Ej. decomp.
Designación química Síntesis análogaal ej. de comp. MD m/z[M+H]+
47
N-(5-biciclo[2.2.1]heptanilmetil)-2-[2-[3-(trifluorometil)fenoxi]etilsulfanil]piridin-3-carboxilamida 51 451,2
48
2-[3-(4-fluorofenil)propilsulfanil]-N-(3,3,3-trifluoropropil)piridin-3-carboxilamida 51 387,1
49
N-(5-biciclo[2.2.1]heptanilmetil)-2-[2-(4-fluorofenoxi)etilsulfanil]piridin-3-carboxilamida 51 401,2
52
N-(5-biciclo[2.2.1]heptanilmetil)-2-(3-naftalen-1-il-propilsulfanil)piridin-3-carboxilamida 51 431,2
53
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[3-fluor-4-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 51 467,2
54
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[4-fluor-3-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 51 467,2
55
N-(ciclooctilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 415,2
56
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(4-metoxifenil)propilsulfanil]piridin-3-carboxilamida 51 411,2
57
2-[3-(4-fluorofenil)propilsulfanil]-N-[(4-metoxifenil)metil]piridin-3-carboxilamida 42 411,1
59
2-[3-(4-fluorofenil)propilsulfanil]-N-[[3-(trifluorometil)fenil]metil]piridin-3-car oxilamida 42 449,1
60
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(3,4-difluorofenil)propilsulfanil]piridin-3-carboxilamida 51 417,2
61
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(3,5-difluorofenil)propilsulfanil]pir n-3-carboxilamida 51 417,2
62
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(2,4-difluorofenil)propilsulfanil]piridin-3-carboxilamida 51 417,2
63
N-[(2-fluorofenil)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 399,1
64
N-[(3-fluorofenil)metil]-2-(3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 399,1
65
N-[(4-fluorofenil)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 399,1
66
N-bencil-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 381,1
67
N-(5-biciclo[2.2.1]heptanilmetil)-2-[(1-metil-3-fenilpropil)sulfanil]piridin-3-carboxilamida 51 395,2
68
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(3,4,5-trifluorofenil)propilsulfanil]piridin-3-carboxilamida 51 435,2
69
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-[3-fluor-5-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 51 467,2
70
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(3-metoxifenil)propilsulfanil]piridin-3-carboxilamida 51 411,2
71
N-[(3,4-difluorofenil)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 417,1
72
N-(2,3-dihidrobenzofuran-5-ilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 423,1
73
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(3-hidroxifenil)propilsulfanil]piridin-3-carboxilamida 58 397,2
74
N-(5-biciclo[2.2.1]heptanilmetil)-2-[[3-(4-fluorofenil)-1-metilpropil]sulfanil]piridin-3-carboxilamida 51 413,2
75
N-(5-biciclo[2.2.1]heptanilmetil)-2-[[3-(4-fluorofenil)-2-metilpropil]sulfanil]piridin-3-carboxilamida 51 413,2
76
2-[3-(4-fluorofenil)propilsulfanil]-N-[(2-metoxifenil)metil]piridin-3-carboxilamida 42 411,1
77
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-metoxifenil)metil]piridin-3-carboxilamida 42 411,1
78
2-[3-(4-fluorofenil)propilsulfanil]-N-fenetilpiridin-3-carboxilamida 42 395,2
79
2-[3-(4-fluorofenil)propilsulfanil]-N-[[4-(trifluorometiloxi)fenil]metil]piridin-3-carboxilamida 42 465,1
80
2-[3-(4-fluorofenil)propilsulfanil]-N-[[4-(trifluorometil)fenil]metil]piridin-3-carboxilamida 42 449,1
81
2-[3-(4-fluorofenil)propilsulfanil]-N-(2-piridin-3-iletil)piridin-3-carboxilam 42 396,1
82
2-[3-(4-fluorofenil)propilsulfanil]-N-(2-piridin-2-iletil)piridin-3-carboxilamida 42 396,1
83
2-[3-(4-fluorofenil)propilsulfanil]-N-[(2-hidroxifenil)metil]piridin-3-carboxilamida 58 397,1
84
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-hidroxifenil)metil]piridin-3-carboxilamida 58 397,1
85
2-[3-(4-fluorofenil)propilsulfanil]-N-[2-(m-tolil)etil]piridin-3-carboxilamida 42 409,2
imagen33
imagen34
Ej. de comp.
Designación química Síntesis análoga al ej. de comp. MD m/z [M+H]+
86
2-[3-(4-fluorofenil)propilsulfanil]-N-[2-(o-tolil)etil]piridin-3-carboxilamida 42 409,2
87
2-[3-(4-fluorofenil)propilsulfanil]-N-[[3-(trifluorometiloxi)fenil]metil]piridin-3-carboxilamida 42 465,1
88
2-[3-(4-fluorofenil)propilsulfanil]-N-[(4-hidroxifenil)metil]piridin-3-carboxilamida 42 397,1
89
2-[3-(4-fluorofenil)propilsulfanil]-N-(2-piridin-4-iletil)piridin-3-carboxilamida 42 396,1
90
2-[3-(4-fluorofenil)propilsulfanil]-N-[2-(p-tolil)etil]piridin-3-carboxilamida 42 409,2
91
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(4-fluorofenil)butilsulfanil]piridin-3-carboxilamida 51 413,2
92
N-(5-biciclo[2.2.1]heptanilmetil)-2-[3-(2,4,5-trifluorofenil)propilsulfanil]piridin-3-carboxilamida 51 435,2
93
2-[3-(4-fluorofenil)propilsulfanil]-N-(3-piridin-2-ilpropil)piridin-3-carboxilamida 42 410,2
94
2-[3-(4-fluorofenil)propilsulfanil]-N-(3-piridin-3-ilpropil)piridin-3-carboxilamida 42 410,2
95
2-[3-(4-fluorofenil)propilsulfanil]-N-(3-piridin-4-ilpropil)piridin-3-carboxilamida 42 410,2
96
2-[3-(4-fluorofenil)propilsulfanil]-N-propilpiridin-3-carboxilamida 42 333,1
97
N-butil-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 42 347,2
98
2-(3-piridin-3-il-propilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 167 370,1
99
2-[3-(p-tolil)propilsulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 167 383,1
100
2-(4-fenil-butilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 51 383,1
101
2-(3-piridin-4-il-propilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 51 370,1
102
2-(3-naftalen-2-il-propilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 51 419,1
103
2-[3-(m-tolil)propilsulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 167 383,1
104
N-(tiofen-2-ilmetil)-2-(3-tiofen-2-il-propilsulfanil)piridin-3-carboxilamida 167 375,1
105
2-[(1-metil-3-fenilpropil)sulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 51 383,1
106
N-(tiofen-2-ilmetil)-2-(3-tiofen-3-il-propilsulfanil)piridin-3-carboxilamida 167 375,1
107
2-[[1-metil-3-[3-(trifluorometil)fenil]propil]sulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 167 451,1
108
2-[(2-bencilciclohexil)sulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 115 423,1
109
2-[3-[3-metil-5-(trifluorometil)fenil]propilsulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 115 451,1
110
2-[4-(3,4-difluorofenil)butilsulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 115 419,1
111
2-(3-piridin-2-il-propilsulfanil)-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 225 370,1
113
2-[3-[4-metil-3-(trifluorometil)fenil]propilsulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 115 451,1
114
2-[(3-fenilciclohexil)sulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 115 409,1
116
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(3,3-dimetilbutil)piridin-3-carboxilamida 115 411,2
117
N-(cicloheptilmetil)-2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]piridin-3-carboxilamida 115 437,2
118
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(tiofen-2-ilmetil)piridin-3-carboxilamida 115 423,1
119
2-[3-(4-fluorofenil)propilsulfanil]-N-(1,2,3,4-tetrahidronaftalen-2-ilmetil)piridin-3-carboxilamida 169 435,2
120
N-(2,3-dihidro-1H-inden-2-il-metil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 421,2
121
N-(1,3-benzodioxol-5-ilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 425,1
122
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-fenilfenil)metil]piridin-3-carboxilamida 169 457,2
123
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-metilciclohexil)metil]piridin-3-carboxilamida 169 401,2
imagen35
Ej. decomp.
Designación química Síntesis análogaal ej. de comp. MD m/z[M+H]+
124
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-[(4-fluorofenil)metil]piridin-3-carboxilamida 115 435,1
125
N-(3,3-dimetil-2-oxobutil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 389,2
127
2-[3-(4-fluorofenil)propilsulfanil]-N-(piridin-3-ilmetil)piridin-3-carboxilamida 169 382,1
128
2-[3-(4-fluorofenil)propilsulfanil]-N-(piridin-4-ilmetil)piridin-3-carboxilam 169 382,1
129
3-[[[2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carbonil]amino]metil]benzoato de metilo 169 439,1
130
2-[3-(4-fluorofenil)propilsulfanil]-N-[3-(2-metoxifenil)propil]piridin-3-carb mida 169 439,2
132
N-[(4-fluorofenil)metil]-2-[[1-metil-3-[3-(trifluorometil)fenil]propil]sulfanil]piridin-3-carboxilamida 51 463,1
133
2-[3-(4-fluorofenil)propilsulfanil]-N-(3-metilbutil)piridin-3-carboxilamida 169 361,2
134
2-[3-(4-fluorofenil)propilsulfanil]-N-(tetrahidropiran-2-ilmetil)piridin-3-carboxilamida 169 389,2
135
2-[3-(4-fluorofenil)propilsulfanil]-N-[3-(1H-pirazol-1-il)propil]piridin-3-carboxilamida 169 399,2
136
2-[3-(4-fluorofenil)propilsulfanil]-N-(naftalen-2-ilmetil)piridin-3-carboxilamida 169 431,2
137
N-(2,3-dihidro-[1,4]benzodioxin-6-ilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 439,1
138
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-morfolin-4-ilfenil)metil]piridin-3-carboxilamida 169 466,2
139
N-(2,3-dihidrobenzofuran-6-il-metil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 423,1
140
2-[3-(4-fluorofenil)propilsulfanil]-N-[[3-(1H-pirazol-1-il)fenil]metil]piridin-3-carboxilamida 169 447,2
141
2-[3-(4-fluorofenil)propilsulfanil]-N-[3-(1H-[1,2,3]triazol-1-il)propil]piridin-3-carboxilamida 169 400,2
142
N-(7-biciclo[2.2.1]heptanilmetil)-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 399,2
144
2-[3-(4-fluorofenil)propilsulfanil]-N-(tiazol-2-ilmetil)piridin-3-carboxilamida 143 388,1
145
2-[3-(4-fluorofenil)propilsulfanil]-N-(tiazol-5-ilmetil)piridin-3-carboxilamida 143 388,1
146
2-[3-(4-fluorofenil)propilsulfanil]-N-(oxazol-2-ilmetil)piridin-3-carboxilamida 143 372,1
148
N-(3,3-dimetilbutil)-2-[3-(4-fluorofenil)propilsulfanil]-4-metilpiridin-3-carboxilamida 147 389,2
149
N-(3,3-dimetilbutil)-2-[[1-metil-3-[3-(trifluorometil)fenil]propil]sulfanil]piridin-3-carboxilamida 115 439,2
150
2-[3-(4-fluorofenil)propilsulfanil]-N-(quinolin-7-ilmetil)piridin-3-carboxilamida 143 432,1
151
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-piridin-2-ilfenil)metil]piridin-3-carboxilamida 143 458,2
152
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-piridin-3-ilfenil)metil]piridin-3-carboxilamida 143 458,2
153
N-(3,3-dimetilbutil)-2-[[(1R)-1-metil-3-fenilpropil]sulfanil]piridin-3-carbo ida 115 371,2
154
N-(3,3-dimetilbutil)-2-[[(1S)-1-metil-3-fenilpropil]sulfanil]piridin-3-carboxilamida 115 371,2
155
2-[(2-bencilciclopentil)sulfanil]-N-(3,3-dimetilbutil)piridin-3-carboxilamida 115 397,2
156
N-(7-biciclo[2.2.1]heptanilmetil)-2-[3-[3-(trifluorometil)fenil]propilsulfanil]piridin-3-carboxilamida 169 449,2
157
2-[3-(4-fluorofenil)propilsulfanil]-N-[3-(1H-[1,2,4]triazol-1-il)propil]piridin-3-carboxilamida 143 400,2
158
2-[3-(4-fluorofenil)propilsulfanil]-N-([1,3,4]oxadiazol-2-ilmetil)piridin-3-carboxilamida 143 373,1
159
2-[3-(4-fluorofenil)propilsulfanil]-N-[(3-piridin-4-ilfenil)metil]piridin-3-carboxilamida 143 458,2
160
N-[[4-(ciclopropilmetil)-3,4-dihidro-2H-[1,4]benzoxazin-6-il]metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 492,2
161
N-[(4-etil-3,4-dihidro-2H-[1,4]benzoxazin-6-il)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 169 466,2
162
2-[3-(4-fluorofenil)propilsulfanil]-N-[(4-metil-3,4-dihidro-2H-[1,4]benzoxazin-6-il)metil]piridin-3-carboxilamida 169 452,2
163
2-[3-(4-fluorofenil)propilsulfanil]-N-(3-metil-3-fenilbutil)piridin-3-carboxilamida 169 437,2
Ej. decomp.
Designación química Síntesis análogaal ej. de comp. MD m/z[M+H]+
164
N-(7-biciclo[2.2.1]heptanilmetil)-2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]piridin-3-carboxilamida 115 435,2
165
2-[[3,3-difluor-3-[3-(trifluorometil)fenil]propil]sulfanil]-N-[(4-fluorofenil)metil]piridin-3-carboxilamida 115 485,1
166
2-[[3,3-difluor-3-[3-(trifluorometil)fenil]propil]sulfanil]-N-(3,3-dimetilbutil)piridin-3-carboxilamida 169 461,2
168
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-[(3-fluorofenil)metil]piridin-3-carboxilamida 169 435,1
170
N-butil-2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]piridin-3-carboxilamida 169 383,1
171
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(2-metoxietil)piridin-3-carboxilamida 169 385,1
172
2-[3-(4-fluorofenil)propilsulfanil]-N-(2-metoxietil)piridin-3-carboxilamida 169 349,1
173
N-[(4-fluor-2-hidroxifenil)metil]-2-[3-(4-fluorofenil)propilsulfanil]piridin-3-carboxilamida 58 415,1
174
2-[3-(4-fluorofenil)propilsulfanil]-N-(furan-2-ilmetil)piridin-3-carboxilamida 169 371,1
175
2-[3-(4-fluorofenil)propilsulfanil]-N-[(5-metilfuran-2-il)metil]piridin-3-car mida 169 385,1
176
N-[(4-fluorofenil)metil]-2-[[3-(4-fluorofenil)-1-metilpropil]sulfanil]piridin-3-carboxilamida 169 413,1
177
2-[[3-(4-fluorofenil)-1-metilpropil]sulfanil]-N-(3-metilbutil)piridin-3-carboxilamida 169 375,2
178
N-(7-biciclo[2.2.1]heptanilmetil)-2-[[3-(4-fluorofenil)-1-metilpropil]sulfanil]piridin-3-carboxilamida 169 413,2
179
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(tetrahidrofuran-2-ilmetil)piridin-3-carboxilamida 169 411,1
180
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(tetrahidropiran-2-ilmetil)piridin-3-carboxilamida 169 425,1
181
2-[3-(4-fluorofenil)propilsulfanil]-N-(tetrahidrofuran-2-ilmetil)piridin-3-carboxilamida 169 375,1
182
2-[3-(4-fluorofenil)propilsulfanil]-N-(2-metoxi-3,3-dimetilbutil)piridin-3-carboxilamida 169 405,2
183
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(m-tolilmetil)piridin-3-carboxilamida 169 431,1
184
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-[(3,5-dimetilfenil)metil]piridin-3-carboxilamida 169 445,1
185
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-propilpiridin-3-carboxilamida 169 369,1
186
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-hexilpiridin-3-carboxilamida 169 411,2
187
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(tetrahidrofuran-3-ilmetil)piridin-3-carboxilamida 169 411,1
188
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(tetrahidropiran-3-ilmetil)piridin-3-carboxilamida 169 425,1
189
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(tetrahidropiran-4-ilmetil)piridin-3-carboxilamida 169 425,1
190
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(furan-2-ilmetil)piridin-3-carboxilamida 169 407,1
191
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-[(5-metilfuran-2-il)metil]piridin-3-carboxilamida 169 421,1
192
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-pentilpiridin-3-carboxilamida 169 397,1
193
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(3-metoxibutil)piridin-3-carboxilamida 169 413,1
194
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(2-metoxipropil)piridin-3-carboxilamida 169 399,1
195
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(2-metoxibutil)piridin-3-carboxilamida 169 413,1
196
3-[[2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]piridin-3-carbonil]amino]propanoato de metilo 169 413,1
197
ácido 3-[[2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]piridin-3-carbonil]am no]propiónico 131 399,1
198
2-[[3,3-difluor-3-(4-fluorofenil)propil]sulfanil]-N-(2-dimetilaminoetil)piridin-3-carboxilamida 169 398,1
199
2-[[3-(3,4-difluorofenil)-1-metilpropil]sulfanil]-N-[(4-fluorofenil)metil]piridin-3-carboxilamida 169 431,1
200
2-[[3-(3,4-difluorofenil)-1-metilpropil]sulfanil]-N-(3-metilbutil)piridin-3-carboxilamida 169 393,2
201
N-[(4-fluorofenil)metil]-2-[[3-(3-fluorofenil)-1-metilpropil]sulfanil]piridin-3-carboxilamida 169 413,1
imagen36
imagen37
imagen38
imagen39
imagen40
imagen41
imagen42

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
    imagen5
    imagen6
    imagen7
    imagen8
ES10708139.0T 2009-03-12 2010-03-11 Nicotinamidas sustituidas como moduladores de KCNQ2/3 Active ES2556772T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09003598 2009-03-12
EP09003598 2009-03-12
PCT/EP2010/001507 WO2010102809A1 (de) 2009-03-12 2010-03-11 Substituierte nicotinamide als kcnq2/3 modulatoren

Publications (1)

Publication Number Publication Date
ES2556772T3 true ES2556772T3 (es) 2016-01-20

Family

ID=40933299

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10708139.0T Active ES2556772T3 (es) 2009-03-12 2010-03-11 Nicotinamidas sustituidas como moduladores de KCNQ2/3

Country Status (28)

Country Link
US (2) US8178684B2 (es)
EP (1) EP2406226B1 (es)
JP (1) JP5670359B2 (es)
KR (1) KR20110132592A (es)
CN (1) CN102369188B (es)
AR (1) AR075540A1 (es)
AU (1) AU2010223511B2 (es)
BR (1) BRPI1008948A2 (es)
CA (1) CA2754998C (es)
CO (1) CO6410303A2 (es)
CY (1) CY1116787T1 (es)
DK (1) DK2406226T3 (es)
EC (1) ECSP11011347A (es)
ES (1) ES2556772T3 (es)
HK (1) HK1166061A1 (es)
HR (1) HRP20151260T1 (es)
HU (1) HUE026170T2 (es)
IL (1) IL214946A (es)
MX (1) MX2011009127A (es)
NZ (1) NZ595628A (es)
PE (1) PE20120780A1 (es)
PL (1) PL2406226T3 (es)
PT (1) PT2406226E (es)
RU (1) RU2529904C2 (es)
SI (1) SI2406226T1 (es)
TW (1) TWI475020B (es)
WO (1) WO2010102809A1 (es)
ZA (1) ZA201107442B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2754934A1 (en) * 2009-03-10 2010-09-16 Gruenenthal Gmbh Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
TWI504395B (zh) * 2009-03-10 2015-10-21 Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TWI461197B (zh) * 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
CA2805932A1 (en) 2010-08-27 2012-03-01 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
PE20131379A1 (es) 2010-08-27 2013-11-29 Gruenenthal Chemie 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores kcnq2/3
HUE024870T2 (en) 2010-08-27 2016-02-29 Gruenenthal Gmbh Substituted 2-oxo and 2-thioxo-dihydroquinoline-3-carboxamides as modulators of KCNQ2 / 3
BR112013005056A2 (pt) 2010-09-01 2016-05-31 Gruenenthal Gmbh 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3
US9168259B2 (en) 2010-10-20 2015-10-27 Grünenthal GmbH Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
EP2630123B1 (en) * 2010-10-20 2017-12-20 Grünenthal GmbH Substituted 6-amino-nicotinamides as kcnq2/3 modulators
AU2015201122B2 (en) * 2010-10-20 2016-02-25 Grunenthal Gmbh Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
FR2968661B1 (fr) * 2010-12-14 2016-01-01 Oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
AU2013248638A1 (en) 2012-04-18 2014-12-04 Grünenthal GmbH Substituted 4-aminobenzamides as KCNQ2/3 modulators
CA2870573A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators
MX2015004511A (es) 2012-10-11 2015-07-06 Grünenthal GmbH Tratamiento y/o profilaxis de enfermedades y/o trastornos provocados por tspo.
AU2013351550A1 (en) 2012-11-28 2015-07-16 Grünenthal GmbH Specific carboxamides as KCNQ2/3 modulators
US9248122B2 (en) 2012-11-28 2016-02-02 Grünenthal GmbH Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
CN104513171B (zh) * 2013-09-30 2017-09-01 中国科学院过程工程研究所 一种玛咖酰胺的合成方法及其用途
CA2965467A1 (en) 2014-10-24 2016-04-28 Ono Pharmaceutical Co., Ltd. Kcnq2-5 channel activator
WO2018110669A1 (en) 2016-12-15 2018-06-21 Ono Pharmaceutical Co., Ltd. Activator of trek (twik related k+ channels) channels
DE102018212006B3 (de) * 2018-07-18 2019-10-31 Universität Greifswald Thioether als Modulatoren von Kv7.2/Kv7.3-Kanälen
CN111840267A (zh) * 2020-08-05 2020-10-30 牡丹江医学院 一种治疗小儿口腔黏膜疾病的药物及其制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2532939A1 (fr) 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
DE4032147A1 (de) 1990-10-10 1992-04-16 Bayer Ag Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung
EP0716077A1 (de) 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
WO1996026925A1 (fr) 1995-03-01 1996-09-06 Banyu Pharmaceutical Co., Ltd. Derives de l'arylthioacetamide
DE19738616A1 (de) 1997-09-04 1999-03-11 Clariant Gmbh 4-Hydroxychinolin-3-carbonsäure-Derivate als Lichtschutzmittel
AU3033500A (en) 1999-01-15 2000-08-01 Agouron Pharmaceuticals, Inc. Non-peptide glp-1 agonists
CA2378243C (en) * 1999-08-04 2012-05-15 Icagen, Inc. Methods for treating or preventing pain and anxiety
DE60037321T4 (de) 1999-08-04 2010-01-07 Icagen, Inc. Benzanilide als öffner des kaliumkanals
MXPA03001422A (es) * 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles substituidos.
EP1441722A2 (en) 2001-02-20 2004-08-04 Bristol-Myers Squibb Company Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases
EP1361879A1 (en) * 2001-02-20 2003-11-19 Bristol-Myers Squibb Company 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
US6593349B2 (en) 2001-03-19 2003-07-15 Icagen, Inc. Bisarylamines as potassium channel openers
AU2002256085A1 (en) 2001-04-06 2002-10-21 Smithkline Beecham Corporation Quinoline inhibitors of hyak1 and hyak3 kinases
EP1542966A1 (en) 2002-09-17 2005-06-22 Pharmacia Corporation Aromatic liver x-receptor modulators
DE60335028D1 (de) 2002-12-23 2010-12-30 Icagen Inc Quinazolinone als kaliumkanalmodulatoren
EP1449841A1 (en) 2003-02-19 2004-08-25 Bayer CropScience SA New fungicidal compounds
AU2004279855A1 (en) * 2003-10-08 2005-04-21 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups
KR20070006890A (ko) * 2004-05-04 2007-01-11 화이자 인코포레이티드 오르토 치환된 아릴 또는 헤테로아릴 아마이드 화합물
EP1814856A1 (en) 2004-11-12 2007-08-08 Galapagos N.V. Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
CA2599890C (en) 2005-03-03 2011-05-03 H. Lundbeck A/S Substituted pyridine derivatives
ES2325558T3 (es) 2005-07-20 2009-09-08 Eli Lilly And Company Derivados de piridina como inhibidores de dipeptidilpeptidasa.
US7670416B2 (en) * 2005-08-04 2010-03-02 I-Tech Ab Use of a combination of substances to prevent biofouling organisms
EP1922311A2 (en) 2005-09-09 2008-05-21 Brystol-Myers Squibb Company Acyclic ikur inhibitors
WO2007057447A1 (en) 2005-11-18 2007-05-24 Neurosearch A/S Novel quinazoline derivatives and their medical use
WO2008011080A2 (en) 2006-07-20 2008-01-24 Amgen Inc. Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine
AU2007275683B2 (en) 2006-07-20 2012-05-10 Amgen Inc. Di-amino-substituted heterocyclic compounds and methods of use
WO2008012532A2 (en) 2006-07-27 2008-01-31 Astrazeneca Ab : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
US20080039542A1 (en) * 2006-08-11 2008-02-14 General Electric Company Composition and associated method
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
DE102007044277A1 (de) * 2007-09-17 2009-03-19 Grünenthal GmbH Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln
JP5497650B2 (ja) 2007-10-19 2014-05-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ１０アンタゴニスト
US8367700B2 (en) 2008-12-17 2013-02-05 Gruenenthal Gmbh Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
CA2754934A1 (en) 2009-03-10 2010-09-16 Gruenenthal Gmbh Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators
TWI504395B (zh) 2009-03-10 2015-10-21 Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
CA2805932A1 (en) 2010-08-27 2012-03-01 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
BR112013004721A2 (pt) 2010-08-27 2016-05-17 Gruenenthal Gmbh "quinolina-3-carboxamidas substituídas como moduladores de kcnq2/3"

Also Published As

Publication number Publication date
CN102369188A (zh) 2012-03-07
NZ595628A (en) 2012-10-26
AU2010223511B2 (en) 2015-06-11
BRPI1008948A2 (pt) 2016-03-15
KR20110132592A (ko) 2011-12-08
IL214946A (en) 2016-02-29
TW201035087A (en) 2010-10-01
HK1166061A1 (en) 2012-10-19
CA2754998C (en) 2013-08-27
CA2754998A1 (en) 2010-09-16
RU2529904C2 (ru) 2014-10-10
JP5670359B2 (ja) 2015-02-18
WO2010102809A1 (de) 2010-09-16
PT2406226E (pt) 2016-01-12
SI2406226T1 (sl) 2015-12-31
US20100234429A1 (en) 2010-09-16
PL2406226T3 (pl) 2016-02-29
US8178684B2 (en) 2012-05-15
ECSP11011347A (es) 2011-10-31
AR075540A1 (es) 2011-04-20
ZA201107442B (en) 2012-07-25
IL214946A0 (en) 2011-11-30
PE20120780A1 (es) 2012-06-20
DK2406226T3 (en) 2015-10-05
EP2406226B1 (de) 2015-09-16
US8586755B2 (en) 2013-11-19
HRP20151260T1 (hr) 2016-01-01
RU2011141186A (ru) 2013-04-20
CN102369188B (zh) 2016-03-02
CY1116787T1 (el) 2017-03-15
HUE026170T2 (en) 2016-05-30
AU2010223511A1 (en) 2011-11-03
CO6410303A2 (es) 2012-03-30
MX2011009127A (es) 2011-09-26
EP2406226A1 (de) 2012-01-18
JP2012520247A (ja) 2012-09-06
US20120184550A1 (en) 2012-07-19
TWI475020B (zh) 2015-03-01

Similar Documents

Publication Publication Date Title
ES2556772T3 (es) Nicotinamidas sustituidas como moduladores de KCNQ2/3
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
RU2007107189A (ru) Производные арилпиридина
NZ599343A (en) Substituted piperidines that increase p53 activity and the uses thereof
RU2012148818A (ru) 2,5,6,7-тетрагидро-[1,4]оксазепин-3-илмаины или 2,3,6,7-тетрагидро-[1,4]оксазепин-5-иламины
HRP20120656T1 (hr) Derivati indazolil amida za liječenje poremećaja posredovanih glukokortikoidnim receptorom
JP2008516946A5 (es)
JP2013501720A5 (es)
JP2013516395A5 (es)
RU2010101633A (ru) Новое сульфонамидное производное малоновой кислоты и его фармацевтическое применение
JP2013517283A5 (es)
RU2008112221A (ru) Соединения ряда изоиндолимидов, их композиции и способы применения
JP2014526549A5 (es)
JP2007532651A5 (es)
RU2013130925A (ru) Оксимовые соединения в качестве средств для повышения уровня холестерина высокой плотности
HRP20141190T1 (hr) Disupstituirani derivati piridina kao antikancerogena sredstva
JP2008500284A5 (es)
NZ596071A (en) Oxazole substituted indazoles as pi3-kinase inhibitors
IL264982B (en) (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
RU2013106755A (ru) 1,4,5,6-тетрагидропиримидин-2-иламины
JP2013519724A5 (es)
JP2013517273A5 (es)
NZ589504A (en) Substituted carbinol compound having cyclic linker
JP2020500192A5 (es)
JP2010540462A5 (es)